抑郁症状和粉样蛋白病理学
Wietse A Wiels1,2, Julie E Oomens3, Sebastiaan Engelborghs4,5,6
1Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.
JAMA psychiatry
|January 22, 2025
概括
老年人的抑郁症状与正常认知中的粉样蛋白病理无关,但与轻度认知障碍中的较低粉样蛋白病理有关. 这些发现表明,其他机制可能是晚年抑郁症的基础.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 精神病学是一个精神病学.
背景情况:
- 抑郁症状与老年人的认知能力下降有关,但潜在的机制尚不清楚.
- 了解抑郁症和粉样蛋白病理之间的关系对于诊断和治疗至关重要.
研究的目的:
- 在没有痴呆症的老年人中调查抑郁症状和粉样蛋白病理之间的关联.
- 检查这种关联是否受到年龄,性别,教育或APOE基因型的影响.
主要方法:
- 来自49项研究的综合数据的横截面分析 (粉样蛋白生物标志物研究).
- 包括9746个具有正常认知 (NC) 的个人和3023个具有轻度认知障碍 (MCI) 的个人.
- 通过脑脊液 (CSF) Aβ1-42或PET扫描来评估粉样蛋白病理;通过验证的天平,诊断或自我报告来评估抑郁症状.
主要成果:
- 在NC个体中,抑郁症状与粉样蛋白病理学无关 (OR,1.13;P=.29).
- 在MCI患者中,抑郁症状与粉样蛋白病理的可能性较低有关 (OR,0.73;P=.001).
- 在NC个体中,抑郁症状与仅在APOE ε4非载体中较高的粉样蛋白病理有关 (平均差异5.0%,P=.02).
结论:
- 抑郁症状在正常认知中并不总是与粉样蛋白病理增加有关,并且与MCI中的粉样蛋白病理减少有关.
- 年龄,性别和教育没有影响这些关联.
- 非粉样蛋白机制可能经常是老年人抑郁症状的基础.
更多相关视频
06:23Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Published on: October 30, 2018
7.9K
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
11.8K
相关概念视频
Alzheimer's Disease: Overview
439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439
Negative and Cognitive Symptoms of Schizophrenia
41
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
41
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
Depressive Disorders: MDD and Dysthymia
50
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
50
Alzheimer's Disease: Treatment
160
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
160
Depression: Overview
211
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
211
